Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

Cited In for PubMed (Select 22670904)

1.

Smoothened variants explain the majority of drug resistance in basal cell carcinoma.

Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, Ally MS, Kim J, Yao C, Chang AL, Oro AE, Tang JY.

Cancer Cell. 2015 Mar 9;27(3):342-53. doi: 10.1016/j.ccell.2015.02.002.

PMID:
25759020
2.

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.

Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK.

Oncotarget. 2015 Feb 28;6(6):3887-903.

3.

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.

Kern D, Regl G, Hofbauer SW, Altenhofer P, Achatz G, Dlugosz A, Schnidar H, Greil R, Hartmann TN, Aberger F.

Oncogene. 2015 Feb 2. doi: 10.1038/onc.2014.450. [Epub ahead of print]

PMID:
25639866
4.

An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma.

Gruber W, Frischauf AM, Aberger F.

Oncoscience. 2014 Sep 16;1(9):567-73. eCollection 2014.

5.

Metastatic Basal cell carcinoma accompanying gorlin syndrome.

Bilir Y, Gokce E, Ozturk B, Deresoy FA, Yuksekkaya R, Yaman E.

Case Rep Oncol Med. 2014;2014:362932. doi: 10.1155/2014/362932. Epub 2014 Nov 19.

6.

Hedgehog pathway blockade with the cancer drug LDE225 disrupts taste organs and taste sensation.

Kumari A, Ermilov AN, Allen BL, Bradley RM, Dlugosz AA, Mistretta CM.

J Neurophysiol. 2015 Feb 1;113(3):1034-40. doi: 10.1152/jn.00822.2014. Epub 2014 Nov 12.

PMID:
25392175
7.

Medicinal history of North American Veratrum.

Chandler CM, McDougal OM.

Phytochem Rev. 2014 Sep;13(3):671-694.

PMID:
25379034
8.

Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds.

Yang H, Cong WN, Yoon JS, Egan JM.

Cancer Med. 2015 Feb;4(2):245-52. doi: 10.1002/cam4.350. Epub 2014 Oct 30.

9.

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.

Bhatia N, Blauvelt A, Brown M, High W, Leonardi CT, Rosen T, Stein Gold L, Stockfleth E, Strober B, Swanson NA, Martin G.

J Clin Aesthet Dermatol. 2014 Jul;7(7 Suppl SC2S5-S22):S5-S22. No abstract available.

10.

Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors.

Shin K, Lim A, Zhao C, Sahoo D, Pan Y, Spiekerkoetter E, Liao JC, Beachy PA.

Cancer Cell. 2014 Oct 13;26(4):521-33. doi: 10.1016/j.ccell.2014.09.001.

PMID:
25314078
11.

Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas.

Yin VT, Merritt H, Esmaeli B.

World J Clin Cases. 2014 Sep 16;2(9):432-8. doi: 10.12998/wjcc.v2.i9.432. Review.

12.

Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.

Lear JT, Corner C, Dziewulski P, Fife K, Ross GL, Varma S, Harwood CA.

Br J Cancer. 2014 Oct 14;111(8):1476-81. doi: 10.1038/bjc.2014.270. Epub 2014 Sep 11.

13.

Sonic hedgehog signaling in Basal cell nevus syndrome.

Athar M, Li C, Kim AL, Spiegelman VS, Bickers DR.

Cancer Res. 2014 Sep 15;74(18):4967-75. doi: 10.1158/0008-5472.CAN-14-1666. Epub 2014 Aug 29. Review.

PMID:
25172843
14.

Modulating the stem cell niche for tissue regeneration.

Lane SW, Williams DA, Watt FM.

Nat Biotechnol. 2014 Aug;32(8):795-803. doi: 10.1038/nbt.2978. Review.

PMID:
25093887
15.

Advanced treatment for basal cell carcinomas.

Atwood SX, Whitson RJ, Oro AE.

Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a013581. doi: 10.1101/cshperspect.a013581. Review.

16.

Basal cell carcinoma-treatments for the commonest skin cancer.

Berking C, Hauschild A, K├Âlbl O, Mast G, Gutzmer R.

Dtsch Arztebl Int. 2014 May 30;111(22):389-95. doi: 10.3238/arztebl.2014.0389. Review.

17.

Targeted treatment for sonic hedgehog-dependent medulloblastoma.

Kieran MW.

Neuro Oncol. 2014 Aug;16(8):1037-47. doi: 10.1093/neuonc/nou109. Epub 2014 Jun 20. Review.

PMID:
24951114
18.

Vismodegib: the proof of concept in Basal cell carcinoma.

Berrada N, Lkhoyali S, Mrabti H, Errihani H.

Clin Med Insights Oncol. 2014 Jun 2;8:77-80. doi: 10.4137/CMO.S14569. eCollection 2014. Review.

19.

Canonical and non-canonical Hedgehog signalling and the control of metabolism.

Teperino R, Aberger F, Esterbauer H, Riobo N, Pospisilik JA.

Semin Cell Dev Biol. 2014 Sep;33:81-92. doi: 10.1016/j.semcdb.2014.05.007. Epub 2014 May 23. Review.

20.

Context-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapy.

Aberger F, Ruiz I Altaba A.

Semin Cell Dev Biol. 2014 Sep;33:93-104. doi: 10.1016/j.semcdb.2014.05.003. Epub 2014 May 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk